4.5 Article

The frontal assessment battery is not useful to discriminate progressive supranuclear palsy from frontotemporal dementias

期刊

PARKINSONISM & RELATED DISORDERS
卷 21, 期 10, 页码 1264-1268

出版社

ELSEVIER SCI LTD
DOI: 10.1016/j.parkreldis.2015.08.006

关键词

Frontal assessment battery; Progressive supranuclear palsy; Frontotemporal dementia; Multiple system atrophy; Parkinson's disease

资金

  1. Hellenic Ministry of Education (THALIS)
  2. Michael J Fox Foundation (Prodromal PPMI)
  3. Ipsen
  4. Halley Stewart Trust through Dystonia Society UK
  5. Wellcome Trust MRC strategic neurodegenerative disease initiative award [WT089698]
  6. Dystonia Coalition
  7. Parkinson's UK [G-1009]
  8. Hellenic Secretariat of Research and Technology (SINERGASIA (COOPERATION), ARISTEIA (EXCELLENCE) I)
  9. EU through FP7 (NEURASYN, MEFOPA, MULTISYN)
  10. Hellenic Secretariat of Research and Technology (ARISTEIA (EXCELLENCE) I)
  11. EU through CIT (LLM)

向作者/读者索取更多资源

Background: The frontal assessment battery (FAB) has been suggested as a useful tool in the differential diagnosis of progressive supranuclear palsy (PSP) from Parkinson's disease (PD) and multiple system atrophy with parkinsonism (MSA-P). However, the utility of the FAB in the differential diagnosis of PSP from frontotemporal dementia (FTD) phenotypes is still under research. Methods: We performed the FAB, in a multi-centre cohort of 70 PSP, 103 FTD (N = 84 behavioral variant FTD, N = 10 semantic dementia, N = 9 progressive non-fluent aphasia), 26 PD and 11 MSA-P patients, diagnosed according to established criteria. Patients were also rated with the mini mental state examination and motor scales. Results: The FAB total score showed a poor discriminatory power between PSP and FTD as a group [area under the curve (AUC) = 0.523]. Moreover, the FAB score showed no correlation with disease duration in PSP (r = 0.05) or FTD group (r = 0.04). In contrast, we confirmed that the FAB is clinically useful to differentiate PSP from PD and MSA-P (AUC = 0.927). In fact, the sum of two FAB subscores together (verbal fluency and Luria motor series) were as good as the total score in differentiating PSP from PD and MSA-P (AUC = 0.957). Conclusions: The FAB may not be a useful tool to differentiate PSP from FTDs, and shows no correlation with disease duration in these disorders. On the other hand, the essential information to differentiate PSP from PD and MSA-P is contained in the sum of only two FAB subscores. This should be taken into consideration in both clinical practice and the planning of clinical trials. (C) 2015 Elsevier Ltd. All rights reserved.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.5
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据